SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $97,751,772 | +48.2% | 806,400 | +40.1% | 0.67% | +58.9% |
Q2 2023 | $65,938,572 | -40.4% | 575,782 | -28.3% | 0.42% | -46.4% |
Q1 2023 | $110,630,405 | +13.6% | 802,658 | +6.8% | 0.78% | +4.1% |
Q4 2022 | $97,404,768 | +48.1% | 751,696 | +26.4% | 0.75% | +43.9% |
Q3 2022 | $65,751,000 | +38.1% | 594,816 | +112.9% | 0.52% | +84.5% |
Q4 2020 | $47,623,000 | -0.9% | 279,328 | -18.4% | 0.28% | -9.0% |
Q3 2020 | $48,049,000 | -0.8% | 342,155 | +13.2% | 0.31% | -6.6% |
Q2 2020 | $48,446,000 | +43.1% | 302,145 | -12.7% | 0.33% | +11.7% |
Q1 2020 | $33,854,000 | -19.6% | 346,086 | +6.1% | 0.30% | -0.7% |
Q4 2019 | $42,103,000 | +74.4% | 326,278 | +1.8% | 0.30% | +55.4% |
Q3 2019 | $24,145,000 | -42.0% | 320,561 | +17.1% | 0.19% | -38.3% |
Q2 2019 | $41,613,000 | +19.8% | 273,857 | -6.0% | 0.31% | +18.6% |
Q1 2019 | $34,742,000 | +24.8% | 291,487 | +14.3% | 0.26% | +11.4% |
Q4 2018 | $27,839,000 | +82.1% | 255,102 | +169.5% | 0.24% | +121.5% |
Q3 2018 | $15,288,000 | – | 94,655 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |